Pharda SRL
1.5 FTEThe score of Pharda shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +10 % Total assets +3 % Headcount (avg FTE) +15 %
Accounts of the company itself (not consolidated).
The full file covers 19 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharda's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 113,407 € | ||||
| Equity | 336,326 € | ||||
| Cash | 148,121 € | ||||
| EBITDA | 235,606 € | ||||
| Total assets | 575,327 € |
Filed annual accounts
- Year ended 30 Sep 2025filed on 17 Mar 2026
- Year ended 30 Sep 2024filed on 16 Dec 2024
- Year ended 30 Sep 2023filed on 21 Dec 2023
- Year ended 30 Sep 2022filed on 10 Jan 2023
- Year ended 30 Sep 2021filed on 12 Jan 2022
Pharda's financial analysis
- Solvency58.5%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharda
Pharda's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0474.979.207
- VAT number
- BE0474979207
- Peppol
- Registered · 0208:0474979207 · as of 08 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Jun 2001
- Registered office
- 6030 Charleroi
- Size
- Micro · 1.5 FTE
- Latest accounts
- 2025 · filed on 17 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharda (SRL) has been based in Charleroi since 2001, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 113,407 € and equity of 336,326 €; its revenue is not published. With 1.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 58.5%, above the median of its sector (41.5%).
Companies similar to Pharda
Companies in the same business, of comparable size and area, outside its group.
- Piret-Lessire Pharma Retail sale of pharmaceutical products Charleroi · balance sheet 574,336 €
- Apotheek Wauters Retail sale of pharmaceutical products Tongeren-Borgloon · balance sheet 575,307 €
- Pharmacie de Stoumont Retail sale of pharmaceutical products Stoumont · balance sheet 574,980 €
- Wpauwels Retail sale of pharmaceutical products Bornem · balance sheet 573,062 €
- Apoteek DE Coster Retail sale of pharmaceutical products Zaventem · balance sheet 578,522 €
- Pharm@dvice Retail sale of pharmaceutical products Fexhe-le-Haut-Clocher · balance sheet 571,791 €
- Belpharma Retail sale of pharmaceutical products Namur · balance sheet 581,313 €
- Sonapha Retail sale of pharmaceutical products Vaux-sur-Sûre · balance sheet 568,273 €
Frequently asked questions about Pharda
What is the revenue of Pharda?
Pharda files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharda?
In Belgium, the VAT number is the company number prefixed with BE: BE0474979207 for Pharda, if the company is VAT-registered. Its company number (CBE) is 0474.979.207.
Where is the registered office of Pharda?
According to the CBE register, the registered office of Pharda is in 6030 Charleroi.
What is the equity of Pharda?
At the close of the 2025 financial year, the equity of Pharda amounts to 336,326 €, a solvency of 58.5% of total assets.
How many people work at Pharda?
1.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharda?
The register lists 1 active mandates at Pharda. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharda
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →